The second and final round of the Clinical Translation and Commercialisation Medtech (CTCM) program opens on 9 September 2022.

The Program offers grants of up to $1.5m (1:1 funding for grants of between $1,000,001 - $1,500,000), with an aim to support early clinical development of medical devices with commercial potential. The three-phase application process starts with an expression of interest submission due by 7 October 2022.


Applicants must be:

  • registered Australian based business
  • incorporated in Australia
  • have an Australian Business Number (ABN)
  • have less than 200 employees.


Eligible projects

Eligible projects include those developing medical device hardware for human use. Hardware innovations should be intended to diagnose, prevent, monitor, treat or alleviate a disease or injury, or modify or monitor anatomy or physiological functions of the body.

Device capability must have been validated through research and/or preclinical studies, and projects must be at Technology Readiness Levels of TRL 4, TRL 5 or TRL 6 at project commencement.

Full program details can be found here.

Please contact the Government Grants team to discuss your project and the application process.

Learn more about how our Government grants services can help you
Learn more about how our Government grants services can help you
Visit our Government grants page